ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

IBIO iBio Inc

2.09
0.00 (0.00%)
26 6월(6) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
iBio Inc IBIO AMEX 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 2.09 08:00:06
개장가 저가 고가 종가 전일 종가
2.09 2.05 2.16 2.09 2.09
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
06/06/202405:10EDGAR2Form 8-K - Current report
04/06/202405:08EDGAR2Form 8-K - Current report
03/06/202420:00GLOBEiBio Closes Sale of Manufacturing Facility in Texas
20/05/202419:55EDGAR2Form 8-K - Current report
14/05/202405:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/05/202405:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/05/202405:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/05/202405:08EDGAR2Form 8-K - Current report
14/05/202405:05GLOBEiBio Reports Fiscal Third Quarter 2024 Financial Results and..
27/03/202420:00GLOBEiBio and AstralBio Announce Transformative AI drug discovery..
27/03/202408:35GLOBEiBio Announces $15.0 Million Private Placement
26/02/202421:59EDGAR2Form 8-K - Current report
26/02/202421:45GLOBEiBio Announces Sale of Preclinical PD-1 Agonist Antibody..
22/02/202406:55EDGAR2Form 8-K - Current report
20/01/202406:36EDGAR2Form 8-K - Current report
16/01/202422:15GLOBEiBio Announces Participation in 23rd Annual PepTalk..
11/01/202403:24EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/01/202406:30EDGAR2Form 8-K - Current report
04/01/202422:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/12/202321:44EDGAR2Form 8-K - Current report
26/12/202321:15GLOBEiBio Amends and Extends Maturity of Credit Agreement
09/12/202306:17EDGAR2Form 8-K - Current report
06/12/202323:13EDGAR2Form 8-K - Current report
06/12/202322:59EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/12/202322:00GLOBEiBio, Inc. Announces Pricing of $4.5 Million Public Offering
05/12/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
30/11/202322:55EDGAR2Form S-1/A - General form for registration of securities..
28/11/202322:36EDGAR2Form 8-K - Current report
28/11/202307:20GLOBEiBio Announces Reverse Stock Split
04/11/202305:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:24GLOBEiBio Further Expands Tech Stack with ShieldTx™; Enhances..
28/10/202305:29EDGAR2Form S-1 - General form for registration of securities under..
26/10/202321:20EDGAR2Form DEF 14A - Other definitive proxy statements
17/10/202305:59EDGAR2Form PRE 14A - Other preliminary proxy statements
10/10/202321:56EDGAR2Form 8-K - Current report
10/10/202321:00GLOBEiBio to Highlight Technology for Advancing Discovery of..
06/10/202305:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202305:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202305:34EDGAR2Form 8-K - Current report
02/10/202319:45GLOBEiBio Explains Recent Filing of Registration Statement
30/09/202306:28EDGAR2Form POS AM - Post-Effective amendments for registration..
28/09/202305:31EDGAR2Form 8-K - Current report
28/09/202305:19GLOBEiBio Announces Filing of 2023 Annual Report on SEC Form 10-K
28/09/202305:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/09/202305:05GLOBEiBio Announces Amendment to Credit Agreement with Woodforest
21/09/202321:00EDGAR2Form 8-K - Current report
31/08/202305:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/08/202305:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/08/202305:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202305:15GLOBEiBio Reports Triple Milestone: In Vivo Proof-of-Concept for..